These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1090 related items for PubMed ID: 1967164

  • 21. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
    Fukata J, Diamond DJ, Martin JB.
    Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
    [Abstract] [Full Text] [Related]

  • 22. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME, Tyler JM, Farmer PK.
    Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
    [Abstract] [Full Text] [Related]

  • 23. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor.
    de Zegher F, Daaboul J, Grumbach MM, Kaplan SL.
    Endocrinology; 1989 Mar; 124(3):1114-7. PubMed ID: 2563681
    [Abstract] [Full Text] [Related]

  • 24. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
    Tannenbaum GS, Ling N.
    Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
    [Abstract] [Full Text] [Related]

  • 25. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries.
    Goodyer CG, Branchaud CL, Lefebvre Y.
    J Clin Endocrinol Metab; 1993 May; 76(5):1259-64. PubMed ID: 8098715
    [Abstract] [Full Text] [Related]

  • 26. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats.
    Ceda GP, Valenti G, Butturini U, Hoffman AR.
    Endocrinology; 1986 May; 118(5):2109-14. PubMed ID: 3009151
    [Abstract] [Full Text] [Related]

  • 27. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes.
    Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ.
    Endocrinology; 1991 Feb; 128(2):1151-8. PubMed ID: 1671214
    [Abstract] [Full Text] [Related]

  • 28. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC, Tannenbaum GS.
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP, Tiberghien C, Rougeot C, Fafeur V, Dray F.
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
    Lengyel AM, Tannenbaum GS.
    Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y, Rivest RW, Eshkol A, Sizonenko PC, Aubert ML.
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [Abstract] [Full Text] [Related]

  • 33. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S, Peng XD, Frohman LA, Kineman RD.
    Neuroendocrinology; 2005 Oct; 81(6):360-71. PubMed ID: 16244497
    [Abstract] [Full Text] [Related]

  • 34. Physiological role of growth hormone (GH)-releasing factor and somatostatin in the dynamics of GH secretion in adult male rat.
    Sato M, Takahara J, Fujioka Y, Niimi M, Irino S.
    Endocrinology; 1988 Oct; 123(4):1928-33. PubMed ID: 2901340
    [Abstract] [Full Text] [Related]

  • 35. Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition.
    Kraicer J, Cowan JS, Sheppard MS, Lussier B, Moor BC.
    Endocrinology; 1986 Nov; 119(5):2047-51. PubMed ID: 2876882
    [Abstract] [Full Text] [Related]

  • 36. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
    Epelbaum J, Enjalbert A, Krantic S, Musset F, Bertrand P, Rasolonjanahary R, Shu C, Kordon C.
    Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pre-exposure of rat anterior pituitary cells to somatostatin enhances subsequent growth hormone secretion.
    Richardson SB, Twente S.
    J Endocrinol; 1991 Jan; 128(1):91-5. PubMed ID: 1671874
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.